Biomarkers in Women with Breast Cancer: I: CEA, CA 15.3, CA 27-29, BRCA1, and BRCA2 Predictive Value
作者： Amina Hamed Alobaidi , Arzo Jalaly , AGM Alsamarai , HH Sarhan
关键词:
摘要: Background: Breast cancer is the most affecting women worldwide and to date of investigated biomarkers are with low sensitivity specificity in early diagnosis primary cancer. Aim: In present study relationship tumor marker panel breast an Iraqi population was investigated. Patients Methods: 100 healthy controls were included study. All patients control groups serum samples subjected for determination CEA, CA15.3, CA27.29, BRCA1, BRCA2. Results: Serum mean values CA 15-3, 27-29, BRCA1 BRCA2 significantly higher than controls. OR relative risk confirm association between increase five markers AUC ROC indicated high their Conclusion:the show evidence that CA15-3, CA27-29 CEA simultaneous arepotintial metastasis treatment minitoring.
ijsrset.com参考文章(53)
L. Rodríguez De Paterna, F. Arnaiz, J. Estenoz, B. Ortuño, E. Lanzós, Study of serum tumor markers CEA, CA 15.3 and CA 27.29 as diagnostic parameters in patients with breast carcinoma: International Journal of Biological Markers. ,vol. 10, pp. 24- 29 ,(1995) , 10.1177/172460089501000105
M Gion, R Mione, A.E Leon, D Lüftner, R Molina, K Possinger, J.F Robertson, CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases. European Journal of Cancer. ,vol. 37, pp. 355- 363 ,(2001) , 10.1016/S0959-8049(00)00396-8
F Canizares, J Sola, M Perez, I Tovar, M De Las Heras, J Salinas, R Penafiel, P Martinez, None, Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis. Tumor Biology. ,vol. 22, pp. 273- 281 ,(2001) , 10.1159/000050627
R. Molina, X. Filella, P. Mengual, M. Prats, G. Zanon, M. Daniels, AM. Ballesta, MCA in patients with breast cancer: correlation with CEA and CA15-3. International Journal of Biological Markers. ,vol. 5, pp. 14- 21 ,(1990) , 10.1177/172460089000500103
Nervana Samy, Halla M. Ragab, Nabila Abd El Maksoud, Mohamed Shaalan, Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up. Cancer Biomarkers. ,vol. 6, pp. 63- 72 ,(2010) , 10.3233/CBM-2009-0119
Marius Nap, Marie-Louise Hammarström, Ole Börmer, Sten Hammarström, Christoph Wagener, Stefan Handt, Magali Schreyer, J P Mach, Franz Buchegger, Sabine von Kleist, Fritz Grunert, Patrick Seguin, Abraham Fuks, Ruth Holm, Rolf Lamerz, Specificity and Affinity of Monoclonal Antibodies against Carcinoembryonic Antigen Cancer Research. ,vol. 52, pp. 2329- 2339 ,(1992)
Alba A Brandes, Mario Ermani, Stefano M M Basso, Franco Lumachi, Duilio Pagano, Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer. Anticancer Research. ,vol. 24, pp. 3221- 3224 ,(2004)
Stefano M M Basso, Bernardo Marzano, Franco Lumachi, Giordano B Chiara, Beata U Waclaw, Manuela Bonamini, Elisa Milan, Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. Anticancer Research. ,vol. 30, pp. 2331- 2334 ,(2010)
D W Chan, R A Beveridge, H Muss, H A Fritsche, G Hortobagyi, R Theriault, D Kiang, B J Kennedy, M Evelegh, Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. Journal of Clinical Oncology. ,vol. 15, pp. 2322- 2328 ,(1997) , 10.1200/JCO.1997.15.6.2322
Freddie Bray, Peter McCarron, D Maxwell Parkin, The changing global patterns of female breast cancer incidence and mortality Breast Cancer Research. ,vol. 6, pp. 229- 239 ,(2004) , 10.1186/BCR932